An in situ analysis of the density of IL-17+ cells in human colorectal cancer specimens showed that a high ‘‘Th17 signature’’ confers severely reduced disease-free survival after the resection of primary tumors [45]. The gene discussed is IL17A; the disease is colorectal cancer.